Rodman & Renshaw Initiates Coverage on Kyverna Therapeutics (NASDAQ:KYTX)
Equities researchers at Rodman & Renshaw began coverage on shares of Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $16.00 price target on the stock. Rodman & Renshaw’s price target points to a potential upside […]
More Stories
Parker-Hannifin Co. (NYSE:PH) Shares Bought by Franklin Street Advisors Inc. NC
Franklin Street Advisors Inc. NC raised its position in shares of Parker-Hannifin Co. (NYSE:PH – Free Report) by 2.7% in...
Clarius Group LLC Trims Stock Holdings in Philip Morris International Inc. (NYSE:PM)
Clarius Group LLC reduced its stake in Philip Morris International Inc. (NYSE:PM – Free Report) by 2.0% during the 3rd...
Independence Bank of Kentucky Buys 971 Shares of Altria Group, Inc. (NYSE:MO)
Independence Bank of Kentucky increased its stake in Altria Group, Inc. (NYSE:MO – Free Report) by 2.3% during the 3rd...
Trevian Wealth Management LLC Buys New Position in Vanguard Extended Market ETF (NYSEARCA:VXF)
Trevian Wealth Management LLC bought a new stake in Vanguard Extended Market ETF (NYSEARCA:VXF – Free Report) in the 3rd...
BWM Planning LLC Acquires Shares of 139,194 ProShares S&P 500 Ex-Energy ETF (NYSEARCA:SPXE)
BWM Planning LLC bought a new stake in ProShares S&P 500 Ex-Energy ETF (NYSEARCA:SPXE – Free Report) during the third...
BWM Planning LLC Takes $1.56 Million Position in Dimensional International Value ETF (NYSEARCA:DFIV)
BWM Planning LLC bought a new stake in Dimensional International Value ETF (NYSEARCA:DFIV – Free Report) in the third quarter,...